The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global End-Stage Kidney Disease Market Research Report 2025
Synopsis
End-stage kidney disease, occurs when chronic kidney disease — the gradual loss of kidney function — reaches an advanced state. In end-stage renal disease, kidneys are no longer able to work as they should to meet body's needs.
The global End-Stage Kidney Disease market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Increasing number of patients suffering from renal or kidney failure and introduction of technologically advanced products, such as low maintenance dialysis equipment and artificial kidney, are the major factors expected to drive the market.
This report aims to provide a comprehensive presentation of the global market for End-Stage Kidney Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding End-Stage Kidney Disease.
Report Scope
The End-Stage Kidney Disease market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global End-Stage Kidney Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the End-Stage Kidney Disease companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Nipro Corporation
Fresenius Medical Care
Baxter International, Inc.
Medtronic Plc
B. Braun Melsungen AG
BD
Asahi Kasei Medical Co., Ltd.
Cantel Medical
Nikkiso Co., Ltd
JMS Co. Ltd.
Segment by Type
Transplantation
Dialysis
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of End-Stage Kidney Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
End-stage kidney disease, occurs when chronic kidney disease — the gradual loss of kidney function — reaches an advanced state. In end-stage renal disease, kidneys are no longer able to work as they should to meet body's needs.
The global End-Stage Kidney Disease market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Increasing number of patients suffering from renal or kidney failure and introduction of technologically advanced products, such as low maintenance dialysis equipment and artificial kidney, are the major factors expected to drive the market.
This report aims to provide a comprehensive presentation of the global market for End-Stage Kidney Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding End-Stage Kidney Disease.
Report Scope
The End-Stage Kidney Disease market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global End-Stage Kidney Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the End-Stage Kidney Disease companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Nipro Corporation
Fresenius Medical Care
Baxter International, Inc.
Medtronic Plc
B. Braun Melsungen AG
BD
Asahi Kasei Medical Co., Ltd.
Cantel Medical
Nikkiso Co., Ltd
JMS Co. Ltd.
Segment by Type
Transplantation
Dialysis
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of End-Stage Kidney Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global End-Stage Kidney Disease Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Transplantation
1.2.3 Dialysis
1.3 Market by Application
1.3.1 Global End-Stage Kidney Disease Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global End-Stage Kidney Disease Market Perspective (2019-2030)
2.2 End-Stage Kidney Disease Growth Trends by Region
2.2.1 Global End-Stage Kidney Disease Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 End-Stage Kidney Disease Historic Market Size by Region (2019-2024)
2.2.3 End-Stage Kidney Disease Forecasted Market Size by Region (2025-2030)
2.3 End-Stage Kidney Disease Market Dynamics
2.3.1 End-Stage Kidney Disease Industry Trends
2.3.2 End-Stage Kidney Disease Market Drivers
2.3.3 End-Stage Kidney Disease Market Challenges
2.3.4 End-Stage Kidney Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top End-Stage Kidney Disease Players by Revenue
3.1.1 Global Top End-Stage Kidney Disease Players by Revenue (2019-2024)
3.1.2 Global End-Stage Kidney Disease Revenue Market Share by Players (2019-2024)
3.2 Global End-Stage Kidney Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by End-Stage Kidney Disease Revenue
3.4 Global End-Stage Kidney Disease Market Concentration Ratio
3.4.1 Global End-Stage Kidney Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by End-Stage Kidney Disease Revenue in 2023
3.5 End-Stage Kidney Disease Key Players Head office and Area Served
3.6 Key Players End-Stage Kidney Disease Product Solution and Service
3.7 Date of Enter into End-Stage Kidney Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 End-Stage Kidney Disease Breakdown Data by Type
4.1 Global End-Stage Kidney Disease Historic Market Size by Type (2019-2024)
4.2 Global End-Stage Kidney Disease Forecasted Market Size by Type (2025-2030)
5 End-Stage Kidney Disease Breakdown Data by Application
5.1 Global End-Stage Kidney Disease Historic Market Size by Application (2019-2024)
5.2 Global End-Stage Kidney Disease Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America End-Stage Kidney Disease Market Size (2019-2030)
6.2 North America End-Stage Kidney Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America End-Stage Kidney Disease Market Size by Country (2019-2024)
6.4 North America End-Stage Kidney Disease Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe End-Stage Kidney Disease Market Size (2019-2030)
7.2 Europe End-Stage Kidney Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe End-Stage Kidney Disease Market Size by Country (2019-2024)
7.4 Europe End-Stage Kidney Disease Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific End-Stage Kidney Disease Market Size (2019-2030)
8.2 Asia-Pacific End-Stage Kidney Disease Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific End-Stage Kidney Disease Market Size by Region (2019-2024)
8.4 Asia-Pacific End-Stage Kidney Disease Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America End-Stage Kidney Disease Market Size (2019-2030)
9.2 Latin America End-Stage Kidney Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America End-Stage Kidney Disease Market Size by Country (2019-2024)
9.4 Latin America End-Stage Kidney Disease Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa End-Stage Kidney Disease Market Size (2019-2030)
10.2 Middle East & Africa End-Stage Kidney Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa End-Stage Kidney Disease Market Size by Country (2019-2024)
10.4 Middle East & Africa End-Stage Kidney Disease Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Nipro Corporation
11.1.1 Nipro Corporation Company Detail
11.1.2 Nipro Corporation Business Overview
11.1.3 Nipro Corporation End-Stage Kidney Disease Introduction
11.1.4 Nipro Corporation Revenue in End-Stage Kidney Disease Business (2019-2024)
11.1.5 Nipro Corporation Recent Development
11.2 Fresenius Medical Care
11.2.1 Fresenius Medical Care Company Detail
11.2.2 Fresenius Medical Care Business Overview
11.2.3 Fresenius Medical Care End-Stage Kidney Disease Introduction
11.2.4 Fresenius Medical Care Revenue in End-Stage Kidney Disease Business (2019-2024)
11.2.5 Fresenius Medical Care Recent Development
11.3 Baxter International, Inc.
11.3.1 Baxter International, Inc. Company Detail
11.3.2 Baxter International, Inc. Business Overview
11.3.3 Baxter International, Inc. End-Stage Kidney Disease Introduction
11.3.4 Baxter International, Inc. Revenue in End-Stage Kidney Disease Business (2019-2024)
11.3.5 Baxter International, Inc. Recent Development
11.4 Medtronic Plc
11.4.1 Medtronic Plc Company Detail
11.4.2 Medtronic Plc Business Overview
11.4.3 Medtronic Plc End-Stage Kidney Disease Introduction
11.4.4 Medtronic Plc Revenue in End-Stage Kidney Disease Business (2019-2024)
11.4.5 Medtronic Plc Recent Development
11.5 B. Braun Melsungen AG
11.5.1 B. Braun Melsungen AG Company Detail
11.5.2 B. Braun Melsungen AG Business Overview
11.5.3 B. Braun Melsungen AG End-Stage Kidney Disease Introduction
11.5.4 B. Braun Melsungen AG Revenue in End-Stage Kidney Disease Business (2019-2024)
11.5.5 B. Braun Melsungen AG Recent Development
11.6 BD
11.6.1 BD Company Detail
11.6.2 BD Business Overview
11.6.3 BD End-Stage Kidney Disease Introduction
11.6.4 BD Revenue in End-Stage Kidney Disease Business (2019-2024)
11.6.5 BD Recent Development
11.7 Asahi Kasei Medical Co., Ltd.
11.7.1 Asahi Kasei Medical Co., Ltd. Company Detail
11.7.2 Asahi Kasei Medical Co., Ltd. Business Overview
11.7.3 Asahi Kasei Medical Co., Ltd. End-Stage Kidney Disease Introduction
11.7.4 Asahi Kasei Medical Co., Ltd. Revenue in End-Stage Kidney Disease Business (2019-2024)
11.7.5 Asahi Kasei Medical Co., Ltd. Recent Development
11.8 Cantel Medical
11.8.1 Cantel Medical Company Detail
11.8.2 Cantel Medical Business Overview
11.8.3 Cantel Medical End-Stage Kidney Disease Introduction
11.8.4 Cantel Medical Revenue in End-Stage Kidney Disease Business (2019-2024)
11.8.5 Cantel Medical Recent Development
11.9 Nikkiso Co., Ltd
11.9.1 Nikkiso Co., Ltd Company Detail
11.9.2 Nikkiso Co., Ltd Business Overview
11.9.3 Nikkiso Co., Ltd End-Stage Kidney Disease Introduction
11.9.4 Nikkiso Co., Ltd Revenue in End-Stage Kidney Disease Business (2019-2024)
11.9.5 Nikkiso Co., Ltd Recent Development
11.10 JMS Co. Ltd.
11.10.1 JMS Co. Ltd. Company Detail
11.10.2 JMS Co. Ltd. Business Overview
11.10.3 JMS Co. Ltd. End-Stage Kidney Disease Introduction
11.10.4 JMS Co. Ltd. Revenue in End-Stage Kidney Disease Business (2019-2024)
11.10.5 JMS Co. Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global End-Stage Kidney Disease Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Transplantation
Table 3. Key Players of Dialysis
Table 4. Global End-Stage Kidney Disease Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global End-Stage Kidney Disease Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global End-Stage Kidney Disease Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global End-Stage Kidney Disease Market Share by Region (2019-2024)
Table 8. Global End-Stage Kidney Disease Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global End-Stage Kidney Disease Market Share by Region (2025-2030)
Table 10. End-Stage Kidney Disease Market Trends
Table 11. End-Stage Kidney Disease Market Drivers
Table 12. End-Stage Kidney Disease Market Challenges
Table 13. End-Stage Kidney Disease Market Restraints
Table 14. Global End-Stage Kidney Disease Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global End-Stage Kidney Disease Market Share by Players (2019-2024)
Table 16. Global Top End-Stage Kidney Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in End-Stage Kidney Disease as of 2023)
Table 17. Ranking of Global Top End-Stage Kidney Disease Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by End-Stage Kidney Disease Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players End-Stage Kidney Disease Product Solution and Service
Table 21. Date of Enter into End-Stage Kidney Disease Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global End-Stage Kidney Disease Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global End-Stage Kidney Disease Revenue Market Share by Type (2019-2024)
Table 25. Global End-Stage Kidney Disease Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global End-Stage Kidney Disease Revenue Market Share by Type (2025-2030)
Table 27. Global End-Stage Kidney Disease Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global End-Stage Kidney Disease Revenue Market Share by Application (2019-2024)
Table 29. Global End-Stage Kidney Disease Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global End-Stage Kidney Disease Revenue Market Share by Application (2025-2030)
Table 31. North America End-Stage Kidney Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America End-Stage Kidney Disease Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America End-Stage Kidney Disease Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe End-Stage Kidney Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe End-Stage Kidney Disease Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe End-Stage Kidney Disease Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific End-Stage Kidney Disease Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific End-Stage Kidney Disease Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific End-Stage Kidney Disease Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America End-Stage Kidney Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America End-Stage Kidney Disease Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America End-Stage Kidney Disease Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa End-Stage Kidney Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa End-Stage Kidney Disease Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa End-Stage Kidney Disease Market Size by Country (2025-2030) & (US$ Million)
Table 46. Nipro Corporation Company Detail
Table 47. Nipro Corporation Business Overview
Table 48. Nipro Corporation End-Stage Kidney Disease Product
Table 49. Nipro Corporation Revenue in End-Stage Kidney Disease Business (2019-2024) & (US$ Million)
Table 50. Nipro Corporation Recent Development
Table 51. Fresenius Medical Care Company Detail
Table 52. Fresenius Medical Care Business Overview
Table 53. Fresenius Medical Care End-Stage Kidney Disease Product
Table 54. Fresenius Medical Care Revenue in End-Stage Kidney Disease Business (2019-2024) & (US$ Million)
Table 55. Fresenius Medical Care Recent Development
Table 56. Baxter International, Inc. Company Detail
Table 57. Baxter International, Inc. Business Overview
Table 58. Baxter International, Inc. End-Stage Kidney Disease Product
Table 59. Baxter International, Inc. Revenue in End-Stage Kidney Disease Business (2019-2024) & (US$ Million)
Table 60. Baxter International, Inc. Recent Development
Table 61. Medtronic Plc Company Detail
Table 62. Medtronic Plc Business Overview
Table 63. Medtronic Plc End-Stage Kidney Disease Product
Table 64. Medtronic Plc Revenue in End-Stage Kidney Disease Business (2019-2024) & (US$ Million)
Table 65. Medtronic Plc Recent Development
Table 66. B. Braun Melsungen AG Company Detail
Table 67. B. Braun Melsungen AG Business Overview
Table 68. B. Braun Melsungen AG End-Stage Kidney Disease Product
Table 69. B. Braun Melsungen AG Revenue in End-Stage Kidney Disease Business (2019-2024) & (US$ Million)
Table 70. B. Braun Melsungen AG Recent Development
Table 71. BD Company Detail
Table 72. BD Business Overview
Table 73. BD End-Stage Kidney Disease Product
Table 74. BD Revenue in End-Stage Kidney Disease Business (2019-2024) & (US$ Million)
Table 75. BD Recent Development
Table 76. Asahi Kasei Medical Co., Ltd. Company Detail
Table 77. Asahi Kasei Medical Co., Ltd. Business Overview
Table 78. Asahi Kasei Medical Co., Ltd. End-Stage Kidney Disease Product
Table 79. Asahi Kasei Medical Co., Ltd. Revenue in End-Stage Kidney Disease Business (2019-2024) & (US$ Million)
Table 80. Asahi Kasei Medical Co., Ltd. Recent Development
Table 81. Cantel Medical Company Detail
Table 82. Cantel Medical Business Overview
Table 83. Cantel Medical End-Stage Kidney Disease Product
Table 84. Cantel Medical Revenue in End-Stage Kidney Disease Business (2019-2024) & (US$ Million)
Table 85. Cantel Medical Recent Development
Table 86. Nikkiso Co., Ltd Company Detail
Table 87. Nikkiso Co., Ltd Business Overview
Table 88. Nikkiso Co., Ltd End-Stage Kidney Disease Product
Table 89. Nikkiso Co., Ltd Revenue in End-Stage Kidney Disease Business (2019-2024) & (US$ Million)
Table 90. Nikkiso Co., Ltd Recent Development
Table 91. JMS Co. Ltd. Company Detail
Table 92. JMS Co. Ltd. Business Overview
Table 93. JMS Co. Ltd. End-Stage Kidney Disease Product
Table 94. JMS Co. Ltd. Revenue in End-Stage Kidney Disease Business (2019-2024) & (US$ Million)
Table 95. JMS Co. Ltd. Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global End-Stage Kidney Disease Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global End-Stage Kidney Disease Market Share by Type: 2023 VS 2030
Figure 3. Transplantation Features
Figure 4. Dialysis Features
Figure 5. Global End-Stage Kidney Disease Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global End-Stage Kidney Disease Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. End-Stage Kidney Disease Report Years Considered
Figure 11. Global End-Stage Kidney Disease Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global End-Stage Kidney Disease Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global End-Stage Kidney Disease Market Share by Region: 2023 VS 2030
Figure 14. Global End-Stage Kidney Disease Market Share by Players in 2023
Figure 15. Global Top End-Stage Kidney Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in End-Stage Kidney Disease as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by End-Stage Kidney Disease Revenue in 2023
Figure 17. North America End-Stage Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America End-Stage Kidney Disease Market Share by Country (2019-2030)
Figure 19. United States End-Stage Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada End-Stage Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe End-Stage Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe End-Stage Kidney Disease Market Share by Country (2019-2030)
Figure 23. Germany End-Stage Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France End-Stage Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. End-Stage Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy End-Stage Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia End-Stage Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries End-Stage Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific End-Stage Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific End-Stage Kidney Disease Market Share by Region (2019-2030)
Figure 31. China End-Stage Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan End-Stage Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea End-Stage Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia End-Stage Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India End-Stage Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia End-Stage Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America End-Stage Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America End-Stage Kidney Disease Market Share by Country (2019-2030)
Figure 39. Mexico End-Stage Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil End-Stage Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa End-Stage Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa End-Stage Kidney Disease Market Share by Country (2019-2030)
Figure 43. Turkey End-Stage Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia End-Stage Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Nipro Corporation Revenue Growth Rate in End-Stage Kidney Disease Business (2019-2024)
Figure 46. Fresenius Medical Care Revenue Growth Rate in End-Stage Kidney Disease Business (2019-2024)
Figure 47. Baxter International, Inc. Revenue Growth Rate in End-Stage Kidney Disease Business (2019-2024)
Figure 48. Medtronic Plc Revenue Growth Rate in End-Stage Kidney Disease Business (2019-2024)
Figure 49. B. Braun Melsungen AG Revenue Growth Rate in End-Stage Kidney Disease Business (2019-2024)
Figure 50. BD Revenue Growth Rate in End-Stage Kidney Disease Business (2019-2024)
Figure 51. Asahi Kasei Medical Co., Ltd. Revenue Growth Rate in End-Stage Kidney Disease Business (2019-2024)
Figure 52. Cantel Medical Revenue Growth Rate in End-Stage Kidney Disease Business (2019-2024)
Figure 53. Nikkiso Co., Ltd Revenue Growth Rate in End-Stage Kidney Disease Business (2019-2024)
Figure 54. JMS Co. Ltd. Revenue Growth Rate in End-Stage Kidney Disease Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
